missing translation for 'onlineSavingsMsg'
Learn More
Learn More
BD Vacutainer™ SST™ II Advance Tubes
Prevents the contamination of the serum from the separated cellular components. BD Vacutainer™ SST™ II Advance Tubes feature an inert, stable gel that separates the serum and the blood clot during centrifugation. The type of gel used enables short centrifugation times.
Brand: BD 368968
This item is not returnable.
View return policy
Description
Using BD SST™ II Advance, routine analytes in clinical chemistry, such as potassium and glucose, are still stable after a week of storage at 2–8°C. Clinical evaluation of special chemistries (such as therapeutic drugs, proteins, peptides, steroids and vitamins) demonstrates a high degree of stability with the acrylic gel in these tubes, which is a distinct advantage during transport and storage.
Advantages of gel tubes versus non-gel tubes:
- Stable barrier between serum and clotted blood, therefore better analyte stability and sample quality
- Optimization of the work flow: short centrifugation time, sample processing and archiving in the primary tube
- No possibility of misidentification due to the use of secondary tubes
Tube usage guidelines:
- Clotting Times: the minimum recommended coagulation time for patients who have not received anti-coagulation treatment is 30 minutes. Tubes contain a clot activator of silica particles.
- Centrifugation Conditions: 1300–2000 g for 10 minutes or alternately 3000 g for 5 minutes, at 18–25°C.
- Effects of Temperature: cooling of the tube during centrifuging can affect the movement capability of the gel. Optimum separation of serum and coagulated blood is achieved at 20–25°C.
- Store at 4–25°C and protected from direct sunlight during storage.
Specifications
| Serum Separator Tube | |
| PET | |
| Hemogard | |
| Red | |
| Used to obtain and separate a serum sample | |
| 13 mm |
| Silica | |
| Sterile | |
| 5 mL | |
| 100 mm | |
| Paper | |
| CE |
Safety and Handling
Signal Word
Hazard Category
Hazard Statement
Precautionary Statement
Supplemental information
- Danger
Hazard Category
- Carcinogenicity Category 1A
- Reproductive toxicity Category 2
Hazard Statement
- H350-May cause cancer.
- H361-Suspected of damaging fertility or the unborn child.
Precautionary Statement
- P201-Obtain special instructions before use.
- P202-Do not handle until all safety precautions have been read and understood.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P308+P313-IF exposed or concerned: Get medical advice/attention.
- P405-Store locked up.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental information
- MIXTURE LIST-Contains : toluene, quartz